Swiss drug company Roche's antibody cocktail used in the treatment of Corona has been approved by Emergency Use in India. The company gave this information on Wednesday. The company reported that its antibody cocktail had received approval from the Central Drugs Standards Control Organization (CDSCO). This approval is based on the data given for Emergency Use in the US and European Union.
So far, two vaccines Covishield and Covaxin are being used to protect against corona in India. Shipment of Russian vaccine Sputnik-V has also arrived in India. Soon it will also be used. In view of the fast-growing cases of Corona, the Government of India has allowed every vaccine to be used in the country, which has been approved by the US, Europe, UK, and WHO.
The medicine will save the condition of the patients from deterioration, Roche India MD V Simpson Emanuel said that we will do everything possible to reduce the pressure from the hospitalization and healthcare system of the patients in India. Antibody cocktails (Casirivimab and Imdevimab) may play an important role in the treatment of corona patients before their condition worsens. This treatment will go along with vaccination in the country and will support our fight against pandemics in India.
What are antibody cocktails?
An antibody cocktail is a mixture of two antibodies that have the same effect on a virus. This antibody cocktail of Roche India has been approved. Cipla has the right to make and market this Roche cocktail antibody in India.
Cipla MD and Global CEO Umang Vohra say that we are committed to exploring all possible treatment options. We are at the forefront of our fight against Corona.